Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.9 USD | -0.81% | -7.89% | -12.81% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 48.84M | Sales 2025 * | 53.68M | Capitalization | 66.61M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.36 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.24 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | -0.81% | ||
1 week | -7.89% | ||
Current month | -16.95% | ||
1 month | -16.95% | ||
3 months | -9.43% | ||
6 months | -19.41% | ||
Current year | -12.81% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.9 | -0.81% | 3,382 |
24-03-27 | 4.94 | -1.59% | 937 |
24-03-26 | 5.02 | -3.46% | 5,272 |
24-03-25 | 5.2 | -3.70% | 6,935 |
24-03-22 | 5.4 | +1.50% | 4,202 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-12.81% | 66.61M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |